Items where authors include "Stephenson, E"

Article

Hardt, K, Vandebosch, A, Sadoff, J et al. (285 more authors) (2022) Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Infectious Diseases, 22 (12). pp. 1703-1715. ISSN 1473-3099

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Angyal, A, Longet, S, Moore, SC et al. (176 more authors) (2022) T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. The Lancet Microbe, 3 (1). e21-e31. ISSN 2666-5247

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

Payne, RP, Longet, S, Austin, JA et al. (132 more authors) (2021) Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell, 184 (23). 5699-5714.e11. ISSN 0092-8674

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Ford, JD orcid.org/0000-0002-2066-3456, Stephenson, E, Cunsolo Willox, A et al. (20 more authors) (2016) Community-based adaptation research in the Canadian Arctic. Wiley Interdisciplinary Reviews: Climate Change, 7 (2). pp. 175-191. ISSN 1757-7780